Table 2.
Outcomes Reported in Trials Comparing Interventions with Family Component to Usual Care or Wait List Control*
| Author, year (ref) | Cancer type | n + | Study quality‡ | Quality of Life | Depression/ anxiety |
Symptom control/ Management |
Relationship adjustment | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Physical functioning | General psychological functioning§ | Social functioning |
Global QoL | |||||||
| Telephone or web-based counseling for family and patients (n = 4) | ||||||||||
| Budin 200822 | breast∥ | 249 | fair | ↔ | ↑ | ↔ | ↑ | |||
| Mishel 200216 | prostate∥ | 239 | fair | ↔/± | ||||||
| Northouse 200521 | breast** | 200 | fair | ↔ | ↔ | ↔ | ||||
| Northouse 200715 | prostate# | 263 | fair | ↔ | ↔ | ↔ | ↔ | ↔ | ||
| Adaptations of couples CBT (n = 5) | ||||||||||
| Baucom 200923 | breast∥ | 14 | fair | ↔++ | ↔ | ↔++ | ↔++ | |||
| Campbell 2004, 200717,18 | prostate | 40 | fair | ↔ | ↔ | ↔ | ||||
| Kayser 201024 | breast∥ | 63 | fair | ↔ | ||||||
| Manne 2005, 200713,25 | breast∥ | 238 | fair | ↔ | ↔ | |||||
| Manne 201119 | prostate∥ | 71 | fair | ↔ | ↔ | |||||
| Family-assisted approaches to patient care (n = 4) | ||||||||||
| Keefe 200526 | any¶ | 78 | fair | ↔ | ↔ | ↔ | ||||
| Kozachik 200127 | any# | 120 | poor | ↔ | ||||||
| McCorkle 200720 | prostate∥ | 126 | poor | ↔ | ↑/↔ | ↔ | ||||
| Nezu 200328 | any∥ | 150 | poor | ↑ | ↔ | ↑ | ↑ | |||
| Family-focused CBT interventions that include family coping and problem solving (n = 4) | ||||||||||
| Blanchard 199629 | any | 86 | fair | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ |
| Kurtz 200531 | any# | 237 | fair | ↑ | ↑ | ↑ | ||||
| McMillan 200732 | any¶ | 329 | fair | ↔ | ↔/↑ | |||||
| Meyers 201130 | any¶ | 476 | fair | ± | ||||||
| Unique intervention (n = 1) | ||||||||||
| Giesler 200514 | prostate∥ | 99 | fair | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ | |
RATINGS: ↑ Family intervention significantly better than comparator; ↔ No significant difference between family intervention and comparator; ↓ Family intervention significantly worse than comparator; ± Significance not reported or could not be determined
*Adapted from expanded evidence report, Griffin et al.6
+Number randomized
‡ Good (low risk of bias): The trial reported adequate allocation concealment, a minimum of single blinding (participants or investigators or assessors are blinded), and that either intent-to-treat analysis was conducted or clear reasons for dropouts/attrition by group were provided. Fair (moderate risk of bias): The trial met or was unclear for allocation concealment and blinding with no more than one of the remaining domains (ITT, withdrawals) unmet. A trial with adequate allocation concealment that did not meet other domains was rated fair. Poor (high risk of bias): The trial had inadequate allocation concealment or blinding and/or clearly met only one of the established risks of bias domains
§Includes broad measures of general psychological functioning or psychological or emotional distress that do not directly correspond with conditions or diagnoses in the Diagnostic and Statistical Manual (DSM)
∥Only early to mid-stage cancer included; ¶Only late-stage cancer included; #All stages of cancer included; **Mid-stage to late-stage cancer included
++Authors report intervention was “superior” to usual care for physical function, symptom control, and relationship adjustment based on medium to large effect sizes; no confidence intervals or p values reported